MIRA INFORM REPORT

 

 

Report Date :

02.06.2012

 

IDENTIFICATION DETAILS

 

Name :

SPANSULES PHARMATECH PRIVATE LIMITED

 

 

Registered Office :

Plot No.59, G-3, Sri Venkateshwara, Towers, Bhagyanagar colony Opposite K.P.H.B Hyderabad - 500072, Andhra Pradesh

 

 

Country :

India

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

09.10.2000

 

 

Com. Reg. No.:

01-035421

 

 

Capital Investment/ Paid-up Capital:

Rs.10.150 Millions

 

 

CIN No.:

[Company Identification No.]

U24230AP2000PTC035421

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

HYDS04126D

 

 

PAN No.:

[Permanent Account No.]

AAFCS7057K

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer and Exporter of Pharmaceuticals Formulations, Pharmaceuticals Pallets and Granules

 

 

No. of Employees:

80 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (46)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 134000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is well established company having satisfactory track. Trade relations are reported as fair. Business is active. Payments are reported to be usually correct and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and Conditions.   

 

 

NOTES:

 

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – September 30, 2011

 

Country Name

Previous Rating

(30.06.2011)

Current Rating

(30.09.2011)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INFORMATION PARTED BY

 

Name :

Mr. Kishore

Designation :

Accounts Manager

Date :

27.04.2012

 

 

LOCATIONS

 

Registered Office/Corporate Office :

Plot No.59, G-3, Sri Venkateshwara, Towers, Bhagyanagar colony Opposite K.P.H.B Hyderabad - 500072, Andhra Pradesh, India

Tel. No.:

91-40-42005216/42005217/40-40130502/23061309

Fax No.:

91-40-23050443/23061979

E-Mail :

info@spansulespharma.com

Website :

http://spansulespharma.com

 

 

Factory:

Plot No.163, Subhash Nagar, IDA, Jeedmetala, Hyderabad -500055

Tel No.:

91-4023194045

Fax No.:

91-40-23095782

 

 

DIRECTORS

 

As on.30.09.2011

Name :

Mr. Guttikonda Venkata Subba Rao

Designation :

Managing Director

Address :

Plot No.59, G-3, Sri Venkateshwara, Towers, Bhagyanagar colony, Kukatpally, District Rangareddy, Hyderabad - 500072, Andhra Pradesh, India

Date of Birth/Age :

15.021964

Date of Appointment :

09.10.2000

Din No.:

01900749

 

 

Name :

Mrs. Guttikonda Rama Devi

Designation :

Director

Address :

Plot No.59, G-3, Sri Venkateshwara, Towers, Bhagyanagar colony, Kukatpally, District Rangareddy,Hyderabad - 500072, Andhra Pradesh, India

Date of Birth/Age :

30.03.1971

Date of Appointment :

09.10.2000

Din No.:

02019526

 

 

 

 

KEY EXECUTIVES

 

Name :

Mr. Kishore

Designation :

Accounts Manager

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on.30.09.2011

 

Names of Shareholders

 

No. of Shares

Mr. Guttikonda Venkata Subba Rao

 

575000

Mrs. Guttikonda Rama Devi

 

440000

Total

 

1015000

 

 

Names of Allottees

 

No. of Shares

Mr. Guttikonda Venkata Subba Rao

 

680620

Mrs. Guttikonda Rama Devi

 

280000

Total

 

960620

 

As on.30.09.2011

 

Category

 

Percentage

 

 

 

Directors or relatives of directors

 

100.00

Total

 

100.00

 


 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Exporter of Pharmaceuticals Formulations, Pharmaceuticals Pallets and Granules

 

 

Products:

Drugs and Medicines

 

 

Exports :

 

Products :

·         Pharmaceuticals Formulations

·         Pharmaceuticals Pallets and Granules

Countries :

·         Malaysia

·         Pakistan

 

 

Imports :

 

Products :

Raw Material

Countries :

China

 

 

Terms :

 

Selling :

Cash/Credit

 

 

Purchasing :

Cash/Credit

 

 

 

 

GENERAL INFORMATION

 

Suppliers :

Nalco Chemicals

 

 

Customers :

Wholesalers, Retailers

Indo Can

 

 

No. of Employees :

80 (Approximately)

 

 

Bankers :

Canara Bank, Moosapet X Road, Specilsed SSI Branch, Kukatpally , Hyderabad, Andhra Pradesh, India

 

 

Facilities :

Rs.in Millions

SECURED LOAN

31.03.2011

31.03.2010

Working Capital Loan

(secured by mortgage of land belongs of promoters and hypothecation of stock of raw material, packing material  and finished goods, Book Debt and Plant and Machinery and further guaranteed of al the directors of the company

17.668

16.346

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Rao and Siva Associates

Chartered Accountant

Address :

Plot No. 121/7, 19th Road, Vivekannanda Nagar, Colony, KukatPally, Hyderabad - 500072, Andhra Pradesh, India

Mobile No.;

9948749499/9491049499

Pan No.:

AGPPM3948Q

 

 

CAPITAL STRUCTURE

 

As on.31.03.2011

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

2000000

Equity Share

Rs.10/- each

Rs.20.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1015000

Equity Share

Rs.10/- each

Rs.10.150 Millions

 

 

 

 

 

 

After 30.09.2011

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

3000000

Equity Share

Rs.10/- each

Rs.30.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1975620

Equity Share

Rs.10/- each

Rs.19.756 Millions

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

31.03.2011

31.03.2010

31.03.2009

 

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

10.150

10.150

1.500

2] Share Application Money

3.947

2.247

8.797

3] Reserves & Surplus

19.340

16.900

14.302

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

33.437

29.297

24.599

LOAN FUNDS

 

 

 

1] Secured Loans

17.668

16.347

11.200

2] Unsecured Loans

0.000

0.000

0.000

TOTAL BORROWING

17.668

16.347

11.200

DEFERRED TAX LIABILITIES

0.620

0.349

0.216

 

 

 

 

TOTAL

51.725

45.993

36.015

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

26.640

19.483

18.237

Capital work-in-progress

4.090

0.217

0.601

 

 

 

 

INVESTMENT

0.000

0.000

0.000

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

20.354

8.309

6.419

 

Sundry Debtors

30.759

22.687

24.695

 

Cash & Bank Balances

0.125

0.692

0.146

 

Other Current Assets

0.000

0.000

0.000

 

Loans & Advances

3.550

9.368

5.298

Total Current Assets

54.788

41.056

36.558

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditor

31.110

11.230

16.579

 

Other Current Liabilities

0.360

1.007

0.477

 

Provisions

2.323

2.526

2.328

Total Current Liabilities

33.793

14.763

19.384

Net Current Assets

20.995

26.293

17.174

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.003

 

 

 

 

TOTAL

51.725

45.993

36.015

 


 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2011

31.03.2010

31.03.2009

 

SALES

 

 

 

 

 

Income

83.588

83.222

88.313

 

 

Other Income

0.076

0.004

0.003

 

 

TOTAL                                     (A)

83.664

83.226

88.316

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Consumption of material and Goods

52.887

53.400

61.433

 

 

Job Wok Charges

0.000

0.910

4.344

 

 

Personal Expenses

12.590

9.661

7.219

 

 

Administrative and Selling expense

11.445

13.270

9.681

 

 

Increase/Decrease in Sock

0.000

0.000

0.160

 

 

TOTAL                                     (B)

76.922

77.241

82.837

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

6.742

5.985

5.479

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

1.537

0.937

1.065

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

5.205

5.048

4.414

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

1.573

1.230

0.912

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

3.632

3.818

3.502

 

 

 

 

 

Less

TAX                                                                  (H)

1.193

1.220

0.821

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

2.439

2.598

2.681

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

16.900

14.302

11.621

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

19.339

16.900

14.302

 

 

 

 

 

 

Earnings Per Share (Rs.)

19.68

25.23

NA

 

 

Particulars

 

 

 

31.03.2012

Sales Turnover(Approximately)

 

 

90.000

 

Expected Sales (2012-2013) : Rs.100.000 Millions

 

The above information has been parted by Mr. Kishore

 

 

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2011

31.03.2010

31.03.2009

PAT / Total Income

(%)

2.92

3.12

3.04

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

4.35

4.59

3.97

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

4.46

6.31

6.40

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.10

0.13

0.14

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

1.54

1.06

1.24

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.62

2.78

1.89

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

Check List by Info Agents

Available in Report [Yes/No]

Year of Establishment

Yes

Locality of the Firm

Yes

Constitution of the firm

Yes

Premises details

Yes

Type of Business

Yes

Line of Business

Yes

Promoters background

Yes

No. of Employees

Yes

Name of Person Contacted

Yes

Designation of contact person

Yes

Turnover of firm for last three years

Yes

Profitability for last three years

Yes

Reasons for variation <> 20%

-

Estimation for coming financial year

-

Capital the business

Yes

Details of sister concerns

No

Major Suppliers

Yes

Major Customers

Yes

Payment Terms

Yes

Export / Import Details [If Applicable]

Yes

Market Information

-

Litigations that the firm / promoter involved in

-

Banking Details

Yes

Banking Facility Details

Yes

Conduct of the banking account

-

Buyer visit details

-

Financials, if provided

Yes

Incorporation details, if applicable

Yes

Last accounts filed at ROC

Yes

Major Shareholders, if applicable

Yes

 

 

Financial Results:

 

For the 11th year of operations company has achieved a profit of Rs.2.439 Millions oaf turnover of Rs.3.588 Millions the Financial year  2010 -11 is challenging for the company. However  the current year will mark the beginning of the growth phase centered around product diversification leading to higher returnes

 

OPERATIONS  

 

The company is focused on ready to fill sustained release pellets in capsules and supplying  to top 10 clients in India and exporting to many cities abroad. Now the company is diversifying in to finished dosage from of generic and ethical. The company has also upgrades its existing facility to WHO GMAP Standers located near Annaram Village , Medak, District Andhra Pradesh

Form 8

 

Corporate identity number of the company

U24230AP2000PTC035421

Name of the company

SPANSULES PHARMATECH PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

Plot No.59, G-3, Sri Venkateshwara, Towers, Bhagyanagar colony Opposite K.P.H.B Hyderabad - 500072,Andhra Pradesh, India

Email: info@spansulespharma.com

This form is for

Creation  of charge

Type of charge

Movable property (not being pledge)

Particular of charge holder

CANARA BANK,  Retail Asset Hub Company, Hyderabad - 500072,Andhra Pradesh, India

Email: vmohancs@gmail.com

Date of instrument Creating the charge

21.10.2010

Amount secured by the charge

Rs.0.300 Millions

Nature, Description and brief particular of the instrument creating modifying the charge

Canara mobile Loan Agreement

Brief of the principal terms an conditions and extent and operation of the charge

Rate of Interests:

Rate Of Interest @ 10% and Subject To Change From Time To Time

 

Terms of Repayment:

Repayable In 36 Equated Monthly Installments of Rs.009 Millions

 

Margin:

As per sanction

 

Extent and Operation of the charge:

 

Charge operates as security to the extent of loan amount of Rs.0.300 Millions along with interest due thereon.

Short particulars of the property or asset(s) charged (including complete address and location of the property)

Hypothecation Of Vehicle Chevrolet Beat New Car Valued By Rs.0.540 Millions

 

FIXED ASSETS

·         Plant and Machinery

·         Furniture and Fixtures

·         Computers

·         Land

·         Building

·         Electrical Equipment

·         Motor Car

·         Air Conditioner

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.55.92

UK Pound

1

Rs.86.03

Euro

1

Rs.69.13

 

 

INFORMATION DETAILS

 

Information Gathered by :

PJA

 

 

Report Prepared by :

BYI

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

46

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.